Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees

We have previously shown that an HIV vaccine regimen including three HIV-DNA immunizations and a single HIV-modified vaccinia virus Ankara (MVA) boost was safe and highly immunogenic in Swedish volunteers. A median 38 months after the first HIV-MVA vaccination, 24 volunteers received 10(8) plaque-fo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nilsson, Charlotta, Godoy-Ramirez, Karina, Hejdeman, Bo, Bråve, Andreas, Gudmundsdotter, Lindvi, Hallengärd, David, Currier, Jeffrey R., Wieczorek, Lindsay, Hasselrot, Klara, Earl, Patricia L., Polonis, Victoria R., Marovich, Mary A., Robb, Merlin L., Sandström, Eric, Wahren, Britta, Biberfeld, Gunnel
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc. 2014
Assuntos:
Vaccines
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938943/
https://ncbi.nlm.nih.gov/pubmed/24090081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2013.0149
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares